转移性结直肠癌的机制
Adrià Cañellas-Socias1,2,3, Elena Sancho4,5, Eduard Batlle6,7,8
1Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. canellas@stanford.edu.
Nature reviews. Gastroenterology & hepatology
|May 28, 2024
概括
由于治疗方法有限,转移性结直肠癌 (mCRC) 仍然是一个挑战. 本综述探讨了驱动CRC转移和治疗耐药性的分子,细胞和微环境因素,旨在改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 翻译医学是一种翻译医学.
背景情况:
- 结肠直肠癌 (CRC) 转移 (mCRC) 提出了重大的治疗挑战和不良预后.
- 与初级CRC相比,mCRC的研究不足,尽管其致死率很高.
研究的目的:
- 审查CRC转移的分子和细胞驱动因素.
- 检查转移性疾病演变的原则.
- 突出瘤微环境对mCRC的影响.
主要方法:
- 文献综述侧重于CRC转移中的遗传变化.
- 在mCRC中分析细胞异质性,可塑性和治疗耐药性.
- 检查瘤的微环境,包括树皮和免疫因素.
主要成果:
- 遗传变化是CRC转移和晚期疾病特征的组成部分.
- 细胞异质性和可塑性有助于转移性传播和治疗耐药性.
- 瘤微环境, stromal 基因程序和免疫背景显著影响mCRC.
结论:
- 了解CRC转移的决定因素对于开发新疗法至关重要.
- 这些领域的未来研究有望彻底改变mCRC治疗和改善生存率.
- 针对分子,细胞和微环境因素为mCRC患者提供了一个有希望的前景.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


